CSF3 and plasma cell myeloma: Topcuoglu et al. performed a retrospective analysis in 84 patients with multiple myeloma and Hodgkin or non-Hodgkin lymphoma, and most of the patients received cyclophosphamide alone or combined with etoposide followed by G-CSF mobilization.